Model
Edge
Ultragenyx Pharmaceutical Inc.
0001603347
Filing Type
4
Filing Date
9/7/2025
Updated
9/8/25, 12:01 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership